NASDAQ · Finance, Insurance & Real Estate · Blank checks
$0.1371+$0.0106 (+8.38%) on the dayAs of the close; data may be delayed.
INV price, last 12 months
$7.32$0.1185
Daily closes over the last 260 trading sessions: −96.6%. Highest close $7.32 on , lowest $0.1185 on . Market data may be delayed.
Key stats
Previous close
$0.1265
Open
$0.1298
Day range
$0.1220 – $0.1407
52-week range
$0.1011 – $7.86
Volume
1.5M
Avg volume (20 days)
3.6M
Market cap
$14.2M
Performance
1W+7.4%
1M−56.2%
3M−89.3%
6M−97.8%
YTD−96.5%
1Y−95.6%
vs S&P 500, 1Y−100.9 pts
Technicals and fundamentals
About Innventure, Inc.
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategies, technology optimization, operations, commercialization, and funding. It has one reportable segment: Technology. The Technology segment includes the business activities of Accelsius, a consolidated subsidiary focused on development and manufacture of data center cooling products.
Chart INV with indicators, scan for setups and get alerts
This page is open to everyone. A free ScanPro account adds the interactive parts, along with watchlists, paper trading with simulated money and the Academy's quizzes.
A full INV chart with indicator overlays, pattern markers and daily, weekly or intraday bars.
Scans of a whole index or list with 72 named conditions, 26 chart setups or a formula of your own.
Alerts and notifications when one fires on a stock you watch, on delayed market data.
Daily range (ATR)36.0%average true range, % of price
52w low $0.101152w high $7.86
Where price sits today against its own history. A description, not a forecast.
Valuation
P/E (trailing)—
P/E (forward)−0.2
PEG—
Price / sales3.47
Price / book0.35
EV / EBITDA—
Company figures as of Nov 20, 2026.
Analysts
ConsensusStrong buy1.0 on 1 (strong buy) to 5 (strong sell)
Analysts2
Average target$3.25+2,126.0% from today
Price targets are opinions and tend to lean optimistic. Only 2 analysts cover it, so one view moves the average.
Earnings
Next results, expectedaround Mar 29, 2027 (in 128 days)A year after its Mar 30, 2026 results release; the last came Nov 12, 2026. An estimate from its SEC filings, not a date the company announced.
Dividends & splits
Paid, last 12 months$0.0000
Yield at today's price—
Change vs the year before—
Jan 10$0.02Apr 26$0.02
Seasonality
-16.2
J
-21.5
F
+13.2
M
+10.5
A
+8.9
M
-10.4
J
-20.1
J
-21.0
A
-24.7
S
-47.1
O
+48.0
N
+6.0
D
Average return in each calendar month, Nov 30, 2024 to Oct 31, 2026. 2 years is 2 observations a month: too few to call a pattern, so read it as history, not a calendar to trade.
Year by year
Year
J
F
M
A
M
J
J
A
S
O
N
D
Year
2026
−21
−14
+38
+67
−18
−5
−36
−60
−56
−44
−92%
2025
−11
−29
−11
−46
+36
−16
−4
+18
+6
−50
+98
−27
−70%
2024
−2
+39
+36%
Each year's monthly returns in %, the observations behind the averages. The last column compounds the year's months; a year the history only partly covers is faded.
Financials
As reported in the company's SEC filings. Latest: Q3 FY2026, ended Sep 30, 2026.
Free shows the latest quarter, the latest year and the last 12 months. Plus shows every period and the growth figures.See Plus
Figures are as each 10-Q and 10-K reported them, in the company's own fiscal calendar, not restated later. A company that changes how it reports a line can make one period look out of step with the rest. Growth compares the same period a year earlier and is left blank when the year before was a loss. Banks and insurers report no gross profit, so rows they don't file are left out. Every filing on SEC EDGAR
Company faces severe liquidity demands, cut 62% of parent staff, suspended new development, stopped funding subsidiaries, and is exploring debt restructuring and asset sales. Stock declined 22.05% on the announcement, indicating significant investor concern about the company's financial viability and shareholder value preservation.
The company is accused of intentionally or recklessly misleading shareholders about a major project that allegedly doesn't exist. Stock price collapsed 55-74%, revenue guidance was suspended, and forensic research contradicted management's claims. A securities class action lawsuit has been filed with substantial investor losses.
Accused of making false statements about a transformative deal with DarkNX that lacked credible evidence, resulting in overstated revenue and cash flow projections.
The company is the subject of a securities fraud class action lawsuit alleging false and misleading statements about a major subsidiary deal, revenue targets, and business prospects. These allegations represent serious legal and reputational risks to the company and its investors.
Company is defendant in securities class action lawsuit alleging false and misleading statements about Accelsius Holdings' transformative deal with DarkNX and overstated revenue targets for 2026.
Company faces securities class action lawsuit, stock crashed 55-74%, removed major project from bookings, suspended revenue guidance, and is accused of making false statements about the viability of the DarkNX project to investors. Forensic research alleged the project was fictitious with no evidence of existence.
Tone is the news provider's automated reading of each article for this stock. It describes the article, not what the price will do.
Figures describe the past, not what the price will do next. Educational tools, not investment advice.